Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
4.800
-0.020 (-0.41%)
At close: Jun 8, 2026, 4:00 PM EDT
4.860
+0.060 (1.25%)
After-hours: Jun 8, 2026, 7:53 PM EDT
Nuvation Bio Market Cap
Nuvation Bio has a market cap or net worth of $1.67 billion as of June 8, 2026. Its market cap has increased by 141.97% in one year.
Market Cap
1.67B
Enterprise Value
1.35B
1-Year Change
141.97%
Ranking
Category
Stock Price
$4.80
Market Cap Chart
Since August 26, 2020, Nuvation Bio's market cap has increased from $174.48M to $1.67B, an increase of 857.92%. That is a compound annual growth rate of 47.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 1.68B | -45.36% |
| Dec 31, 2025 | 3.07B | 243.11% |
| Dec 31, 2024 | 895.27M | 170.80% |
| Dec 29, 2023 | 330.61M | -21.16% |
| Dec 30, 2022 | 419.31M | -77.35% |
| Dec 31, 2021 | 1.85B | 779.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 26, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zymeworks | 1.76B |
| Viridian Therapeutics | 1.74B |
| Rapport Therapeutics | 1.73B |
| AbCellera Biologics | 1.72B |
| Agios Pharmaceuticals | 1.68B |
| uniQure | 1.67B |
| Sarepta Therapeutics | 1.66B |
| Innoviva | 1.66B |